2025
SJR Q2
JCR Q3 · 2,6
63 matched articles
SCIE
Journal detail
Prostaglandins and Other Lipid Mediators
- Publisher
- Elsevier Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
10988823
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,699
- Quartile Q2
- H-Index 92
- Cites/doc 2,76
- Docs (3y) 185
- Cites (3y) 522
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,6
- 5Y JIF 2,8
- JCI 0,44
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Biochemistry Q2
- Cell Biology Q3
- Pharmacology Q2
- Physiology Q3
Areas
- Biochemistry, Genetics and Molecular Biology
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Biochemistry & Molecular Biology | Cell Biology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,699 | 2,6 | 2,8 | 0,44 | Q3 | 92 |
| 2024 | Q2 | Q3 | 0,699 | 2,5 | 2,6 | 0,49 | Q3 | 89 |
| 2023 | Q2 | Q3 | 0,671 | 2,5 | 2,8 | 0,45 | Q4 | 89 |
| 2022 | Q2 | Q3 | 0,733 | 2,9 | 2,9 | 0,5 | Q3 | 89 |
| 2021 | Q2 | Q3 | 0,796 | 3,8 | 3,2 | 0,5 | Q3 | 89 |
| 2020 | Q2 | Q3 | 0,81 | 3,1 | 3,4 | 0,49 | Q3 | 89 |
| 2019 | Q2 | Q3 | 0,753 | 2,3 | 2,5 | 0,45 | Q4 | 89 |
| 2018 | — | Q3 | — | 2,3 | 2,9 | 0,46 | Q4 | — |
| 2017 | Q1 | Q2 | 1,191 | 3 | 3 | 0,48 | Q3 | 89 |
| 2016 | Q1 | Q3 | 1,341 | 2,6 | 2,9 | — | — | 89 |
| 2015 | Q1 | Q2 | 1,162 | 2,9 | 2,6 | — | — | 89 |
| 2014 | Q1 | Q3 | 1,254 | 2,4 | 2,7 | — | — | 89 |
| 2013 | Q1 | Q2 | 1,082 | 2,9 | 2,6 | — | — | 89 |
| 2012 | Q1 | Q3 | 1,081 | 2,4 | 2,4 | — | — | 89 |
| 2011 | Q2 | Q3 | 0,951 | 2,7 | 2,5 | — | — | 89 |
| 2010 | Q1 | Q3 | 1,146 | 2 | 2,3 | — | — | 89 |
| 2009 | — | Q3 | — | 2,6 | 2,3 | — | — | — |
| 2008 | — | Q3 | — | 2,3 | 2,2 | — | — | — |
| 2007 | — | Q3 | — | 2 | 2,9 | — | — | — |
| 2006 | — | Q3 | — | 2 | — | — | — | — |
| 2005 | — | Q3 | — | 2,3 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q4 | 224/328 |
| 2025 | CELL BIOLOGY | SCIE | Q3 | Q3 | 151/207 |
| 2024 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 214/320 |
| 2024 | CELL BIOLOGY | SCIE | Q3 | Q3 | 147/204 |
| 2023 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q4 | 216/313 |
| 2023 | CELL BIOLOGY | SCIE | Q3 | Q4 | 148/205 |
| 2022 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 192/285 |
| 2022 | CELL BIOLOGY | SCIE | Q3 | Q3 | 137/191 |
| 2021 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 173/297 |
| 2021 | CELL BIOLOGY | SCIE | Q3 | Q3 | 130/195 |
| 2020 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 194/295 |
| 2020 | CELL BIOLOGY | SCIE | Q3 | Q3 | 141/195 |
| 2019 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q4 | 207/297 |
| 2019 | CELL BIOLOGY | SCIE | Q4 | Q4 | 148/195 |
| 2018 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q4 | 202/299 |
| 2018 | CELL BIOLOGY | SCIE | Q4 | Q4 | 146/193 |
| 2017 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q3 | 142/293 |
| 2017 | CELL BIOLOGY | SCIE | Q3 | Q3 | 110/190 |
| 2016 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 153/290 |
| 2016 | CELL BIOLOGY | SCIE | Q3 | — | 120/190 |
| 2015 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 127/289 |
| 2015 | CELL BIOLOGY | SCIE | Q3 | — | 103/187 |
| 2014 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 171/290 |
| 2014 | CELL BIOLOGY | SCIE | Q3 | — | 127/184 |
| 2013 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 145/291 |
| 2013 | CELL BIOLOGY | SCIE | Q3 | — | 106/185 |
| 2012 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 178/290 |
| 2012 | CELL BIOLOGY | SCIE | Q3 | — | 119/185 |
| 2011 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 157/290 |
| 2011 | CELL BIOLOGY | SCIE | Q3 | — | 110/181 |
| 2010 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 193/286 |
| 2010 | CELL BIOLOGY | SCIE | Q3 | — | 130/178 |
| 2009 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 145/283 |
| 2009 | CELL BIOLOGY | SCIE | Q3 | — | 98/162 |
| 2008 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 163/275 |
| 2008 | CELL BIOLOGY | SCIE | Q3 | — | 101/157 |
| 2007 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 170/263 |
| 2007 | CELL BIOLOGY | SCIE | Q3 | — | 108/156 |
| 2006 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 166/262 |
| 2006 | CELL BIOLOGY | SCIE | Q3 | — | 109/156 |
| 2005 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 132/261 |
| 2005 | CELL BIOLOGY | SCIE | Q3 | — | 79/153 |